Two component modifications
A fictional patient is scheduled to receive a cellular blood component after a treatment associated with an indication for irradiation. The transfusion request lists leukoreduction, and a trainee assumes this automatically meets the irradiation requirement because both processes involve white cells. The record has not yet confirmed that the selected component was irradiated. The supervising clinician asks the team to identify the different mechanisms, verify the actual product and clarify the request before administration. The case does not ask for a particular irradiation dose or universal duration of need after every therapy. The task is to prevent a terminology shortcut from substituting one modification for another clinically indicated safety measure.
1. Why are the terms not interchangeable?
Read the worked answer
Leukoreduction reduces leukocyte content, while irradiation addresses the ability of viable donor lymphocytes to cause transfusion-associated graft-versus-host disease.
2. What should the team verify?
Read the worked answer
Confirm the patient indication, required component modification and actual product documentation rather than assume that one label automatically implies the other.